Kymera Therapeutics (KYMR) Interest Coverage Ratio (2019 - 2026)

Kymera Therapeutics (KYMR) has 8 years of Interest Coverage Ratio data on file, last reported at 0.2 in Q1 2026.

• On a quarterly basis, Interest Coverage Ratio rose 66.41% year-over-year to 0.2 in Q1 2026; TTM through Mar 2026 was 0.87, a 61.65% increase from a year earlier, with the FY2025 full-year figure at 0.87, up 21.24% from the prior year.
• Interest Coverage Ratio for Q1 2026 stood at 0.2, up from 0.37 in the prior quarter.
• Over the last five years, Interest Coverage Ratio for KYMR reached as high as 0.12 in Q4 2023 and fell as low as 5047.19 in Q4 2024.
• Historically, Interest Coverage Ratio has averaged 359.81 across 5 years, with a median of 0.55 in 2025.
• Across the five-year window, Interest Coverage Ratio soared 99.98% in 2023 and plunged 4243567.51% in 2024, its largest moves.
• Year by year, Interest Coverage Ratio stood at 702.36 in 2022, then surged by 99.98% to 0.12 in 2023, then plunged by 4243567.51% to 5047.19 in 2024, then jumped by 99.99% to 0.37 in 2025, then jumped by 44.61% to 0.2 in 2026.
• Per Business Quant data, the three most recent Interest Coverage Ratio figures were 0.2 in Q1 2026, 0.37 in Q3 2025, and 0.63 in Q2 2025.